Global Drug Discovery Technologies Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Drug Discovery Technologies Market Research Report 2024
This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
According to MRAResearch’s new survey, global Drug Discovery Technologies market is projected to reach US$ 76370 million in 2033, increasing from US$ 48000 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2033.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Discovery Technologies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Drug Discovery Technologies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Drug Discovery Technologies market is projected to reach US$ 76370 million in 2033, increasing from US$ 48000 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2033.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Discovery Technologies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Drug Discovery Technologies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source